Cvi Holdings, LLC Evelo Biosciences, Inc. Transaction History

Cvi Holdings, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 16, 2023	SELL	$0.17 - $1.57 $107,269 - $990,662	-630,995 Reduced 42.88%	840,577 $151,000
Q4 2022 Feb 14, 2023	SELL	$1.44 - $48.2 $319,799 - $10.7 Million	-222,083 Reduced 13.11%	1,471,572 $2.37 Million
Q3 2022 Nov 14, 2022	SELL	$1.86 - $41.8 $671,718 - $15.1 Million	-361,139 Reduced 17.58%	1,693,655 $3.54 Million
Q2 2022 Aug 15, 2022	BUY	$1.46 - $3.55 $3 Million - $7.29 Million	2,054,794 New	2,054,794 $4.34 Million

Ticker EVLO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,994,000
Description
Evelo Biosciences, Inc., a biotechnology company, discovers and develops oral biologics for the treatment of inflammatory diseases and cancer. It is developing EDP1815, a whole-microbe candidate for the treatment of inflammatory diseases; and is in Phase 2 clinical trial for the treatment of psoriasis and atopic dermatitis, as well as for the hy...

Get notified when there are updates to the investment portfolio of Cvi Holdings, LLC, based on Form 13F filings with the SEC.

Stay updated on Cvi Holdings, LLC with notifications on news.